ComparisonBiomarkers

ApoB vs LDL-C

Particle count vs cholesterol mass for heart risk

ApoBAtherogenic particle count

LDL-CCholesterol carried in LDL

Last reviewed: July 2026
Version: 1.0
Review cadence: Annually

At a Glance

The 30-second view

What it measures
ApoB
Particle number
LDL-C
Cholesterol mass
Accuracy for risk
ApoB
Higher (esp. high TG / diabetes)
LDL-C
Good; established
Availability
ApoB
Widely available
LDL-C
Universal
Cost
ApoB
Slightly higher
LDL-C
Very low
Fasting
ApoB
Not required
LDL-C
Sometimes

Dimension	ApoB	LDL-C
What it measures	Particle number	Cholesterol mass
Accuracy for risk	Higher (esp. high TG / diabetes)	Good; established
Availability	Widely available	Universal
Cost	Slightly higher	Very low
Fasting	Not required	Sometimes

Overview

Both estimate atherogenic-lipoprotein risk. ApoB counts the number of artery-damaging particles directly; LDL-C measures the cholesterol those particles carry.

Quick summary

ApoB is generally the more accurate single marker of cardiovascular risk — especially when triglycerides are high or in diabetes — while LDL-C is more widely available, cheaper, and has established treatment targets. They usually agree; when they disagree, ApoB is the better guide.

When each is appropriate

Choose ApoB

When precision matters: high triglycerides, diabetes, metabolic syndrome, or when LDL-C looks reassuring but risk seems higher (discordance).

Choose LDL-C

For universal availability, low cost, and long-established, guideline-based targets.

Evidence comparison

What it measures
ApoB
Particle number
LDL-C
Cholesterol mass in LDL
Captures remnant particles
ApoB
Yes (all ApoB particles)
LDL-C
No
Fasting required
ApoB
No
LDL-C
Sometimes (calculated)
Guideline role
ApoB
Secondary / emerging target
LDL-C
Primary / established target
When they disagree
ApoB
Reclassifies risk upward
LDL-C
Can understate risk

Dimension	ApoB	LDL-C
What it measures	Particle number	Cholesterol mass in LDL
Captures remnant particles	Yes (all ApoB particles)	No
Fasting required	No	Sometimes (calculated)
Guideline role	Secondary / emerging target	Primary / established target
When they disagree	Reclassifies risk upward	Can understate risk

Cost & accessibility

Cost & availability
ApoB
Slightly higher; widely available
LDL-C
Very low; universal

Dimension	ApoB	LDL-C
Cost & availability	Slightly higher; widely available	Very low; universal

Strengths & limitations

ApoB

Directly counts atherogenic particles

More accurate in high-triglyceride / diabetic profiles

No fasting needed

Slightly less available; fewer fixed targets

LDL-C

Universally available and inexpensive

Established guideline targets

Familiar to clinicians and patients

Can understate risk when triglycerides are high or in diabetes

Frequently asked questions

Should I ask for ApoB instead of LDL-C?

If available and affordable, ApoB adds accuracy, particularly with high triglycerides or diabetes. LDL-C remains perfectly useful for most people, and the two usually point the same way.

Continue Exploring

Where to go next

References & sources

2018 ACC/AHA Cholesterol Guideline
2019 ESC/EAS Dyslipidaemia Guidelines

Comparisons synthesize BioSignal's existing calibrated evidence — they introduce no new conclusions. Figures and verdicts trace to the linked Signal Records and Foundations.

Educational information — not medical advice

Comparisons orient a decision; they don't make it for you. Choices between medications, supplements, or programs belong with a qualified clinician. See our Medical Disclaimer.

Is this comparison clear, balanced, and useful? Your feedback shapes what we review next.

Give feedback